AMGN:NASDAQ
Amgen Inc
421,51 $
arrow_downward
-0,50%(-2,13) 1D
421,00 $
arrow_downward
-0,12% (-0,51)bedtimeAfter hours
Closed: 30 սեպ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN...
Open
424,01 $
High
426,59 $
Low
420,63 $
Mkt. cap
227,88 մլրդ
Avg. vol.
2,89 մլն
Volume
2,91 մլն
Dividend
2,39%
Quarterly dividend
2,52 $
Ex-dividend date
21 օգս, 2026 թ.
P/E ratio
26,18
52-wk high
447,01 $
52-wk low
283,00 $
EPS
16,10 $
Beta
0,43
Shares outstanding
540,63 մլն
No. of employees
32 հզր
Open
424,01 $
High
426,59 $
Low
420,63 $
Mkt. cap
227,88 մլրդ
Avg. vol.
2,89 մլն
Volume
2,91 մլն
Dividend
2,39%
Quarterly dividend
2,52 $
Ex-dividend date
21 օգս, 2026 թ.
P/E ratio
26,18
52-wk high
447,01 $
52-wk low
283,00 $
EPS
16,10 $
Beta
0,43
Shares outstanding
540,63 մլն
No. of employees
32 հզր
News stories
From web sources and news partners
Simply Wall St
·
5 ժամ առաջ
Is Amgen (AMGN) Undervalued Following Its Phase 3 Sjögren's Disease Trial Update?
AD HOC NEWS
·
12 ժամ առաջ
Amgen stock trades at EUR 372.83 after mixed analyst calls
GuruFocus
·
20 ժամ առաջ
Amgen Inc (AMGN) Shares Surge 1.3% -- What GF Score of 87 Tells Investors
News Corp
·
1 օր առաջ
Amgen Inc. stock outperforms competitors on strong trading day
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees31,5 հզր
Founded08 ապր, 1980 թ.
HeadquartersԹաուզենդ Օուքս, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websiteamgen.com